Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Tumor Microenvironment Collagen Signature (CSTME) Associates With the Prognosis of Stage II and III Colorectal Cancer : A Multi-Center Retrospective Observational Cohort Study

NCT05420415 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT05420415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05420415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Tumor Microenvironment Collagen Signature (CSTME) Associates With the Prognosis of Stage II and III Colorectal Cancer : A Multi-Center Retrospective Observational Cohort Study
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Observational
Overall status
Completed
Start date
September 1, 2018
Completion date
May 1, 2022
Enrollment
570 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer